Based in Graz, Austria, ORIDIS Biomarkers is a Contract Research Organization founded in 2011, specializing in conducting tissue and body fluid-based studies in cancer research through a TISSOMICS™ approach.

At ORIDIS Biomarkers, we guide our clients through the entire research and development process, combining our extensive in-house knowledge and technologies with access to a unique network of partners.

Our network of partners include public and commerical biobanks, clinical research units and partners in the field of in-vitro diagnostics, enabling us to provide experience in clinical cohort design and to offer diagnostic assays custom-made to our client’s specific project requirements.

In addition, our research activities have lead to the development of proprietary technologies and filing of eight patents in in-vitro diagnostics and image analysis.